614 related articles for article (PubMed ID: 19434693)
1. The dual role of thymidine phosphorylase in cancer development and chemotherapy.
Bronckaers A; Gago F; Balzarini J; Liekens S
Med Res Rev; 2009 Nov; 29(6):903-53. PubMed ID: 19434693
[TBL] [Abstract][Full Text] [Related]
2. Thymidine phosphorylase and fluoropyrimidines efficacy: a Jekyll and Hyde story.
Ciccolini J; Evrard A; Cuq P
Curr Med Chem Anticancer Agents; 2004 Mar; 4(2):71-81. PubMed ID: 15032715
[TBL] [Abstract][Full Text] [Related]
3. Targeting platelet-derived endothelial cell growth factor/thymidine phosphorylase for cancer therapy.
Liekens S; Bronckaers A; Pérez-Pérez MJ; Balzarini J
Biochem Pharmacol; 2007 Dec; 74(11):1555-67. PubMed ID: 17572389
[TBL] [Abstract][Full Text] [Related]
4. Role of thymidine phosphorylase in biomodulation of fluoropyrimidines.
Morita T; Matsuzaki A; Suzuki K; Tokue A
Curr Pharm Biotechnol; 2001 Sep; 2(3):257-67. PubMed ID: 11530879
[TBL] [Abstract][Full Text] [Related]
5. Recent discovery of non-nucleobase thymidine phosphorylase inhibitors targeting cancer.
Bera H; Chigurupati S
Eur J Med Chem; 2016 Nov; 124():992-1003. PubMed ID: 27783978
[TBL] [Abstract][Full Text] [Related]
6. Thymidine phosphorylase: a two-face Janus in anticancer chemotherapy.
Focher F; Spadari S
Curr Cancer Drug Targets; 2001 Aug; 1(2):141-53. PubMed ID: 12188887
[TBL] [Abstract][Full Text] [Related]
7. Regulation of expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in human colon carcinoma cells.
Schwartz EL; Wan E; Wang FS; Baptiste N
Cancer Res; 1998 Apr; 58(7):1551-7. PubMed ID: 9537263
[TBL] [Abstract][Full Text] [Related]
8. The rôle of thymidine phosphorylase/PD-ECGF in cancer chemotherapy: a chemical perspective.
Cole C; Foster AJ; Freeman S; Jaffar M; Murray PE; Strafford IJ
Anticancer Drug Des; 1999 Oct; 14(5):383-92. PubMed ID: 10766293
[TBL] [Abstract][Full Text] [Related]
9. Interferon induces thymidine phosphorylase/platelet-derived endothelial cell growth factor expression in vivo.
Makower D; Wadler S; Haynes H; Schwartz EL
Clin Cancer Res; 1997 Jun; 3(6):923-9. PubMed ID: 9815767
[TBL] [Abstract][Full Text] [Related]
10. The role of thymidine phosphorylase, an angiogenic enzyme, in tumor progression.
Akiyama S; Furukawa T; Sumizawa T; Takebayashi Y; Nakajima Y; Shimaoka S; Haraguchi M
Cancer Sci; 2004 Nov; 95(11):851-7. PubMed ID: 15546501
[TBL] [Abstract][Full Text] [Related]
11. Platelet-derived endothelial cell growth factor thymidine phosphorylase in tumour growth and response to therapy.
Griffiths L; Stratford IJ
Br J Cancer; 1997; 76(6):689-93. PubMed ID: 9310231
[TBL] [Abstract][Full Text] [Related]
12. [Thymidine phosphorylase and angiogenesis].
Akiyama S
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1208-11. PubMed ID: 10945018
[TBL] [Abstract][Full Text] [Related]
13. Prevention of hypoxia-induced apoptosis by the angiogenic factor thymidine phosphorylase.
Kitazono M; Takebayashi Y; Ishitsuka K; Takao S; Tani A; Furukawa T; Miyadera K; Yamada Y; Aikou T; Akiyama S
Biochem Biophys Res Commun; 1998 Dec; 253(3):797-803. PubMed ID: 9918807
[TBL] [Abstract][Full Text] [Related]
14. The influence of elevated levels of platelet-derived endothelial cell growth factor/thymidine phosphorylase on tumourigenicity, tumour growth, and oxygenation.
Griffiths L; Stratford IJ
Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):877-83. PubMed ID: 9845114
[TBL] [Abstract][Full Text] [Related]
15. Induction of thymidine phosphorylase in both irradiated and shielded, contralateral human U87MG glioma xenografts: implications for a dual modality treatment using capecitabine and irradiation.
Blanquicett C; Gillespie GY; Nabors LB; Miller CR; Bharara S; Buchsbaum DJ; Diasio RB; Johnson MR
Mol Cancer Ther; 2002 Oct; 1(12):1139-45. PubMed ID: 12481438
[TBL] [Abstract][Full Text] [Related]
16. Role of platelet derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivity and potential role of deoxyribose-1-phosphate.
de Bruin M; van Capel T; Smid K; van der Born K; Fukushima M; Hoekman K; Pinedo HM; Peters GJ
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1485-90. PubMed ID: 15571282
[TBL] [Abstract][Full Text] [Related]
17. Thymidine phosphorylase (platelet-derived endothelial cell growth factor) as a target for capecitabine: from biology to the bedside.
Ranieri G; Roccaro AM; Vacca A; Ribatti D
Recent Pat Anticancer Drug Discov; 2006 Jun; 1(2):171-83. PubMed ID: 18221035
[TBL] [Abstract][Full Text] [Related]
18. Making capecitabine targeted therapy for breast cancer: which is the role of thymidine phosphorylase?
Bonotto M; Bozza C; Di Loreto C; Osa EO; Poletto E; Puglisi F
Clin Breast Cancer; 2013 Jun; 13(3):167-72. PubMed ID: 23218471
[TBL] [Abstract][Full Text] [Related]
19. Thymidine phosphorylase expression and benefit from capecitabine in patients with advanced breast cancer.
Andreetta C; Puppin C; Minisini A; Valent F; Pegolo E; Damante G; Di Loreto C; Pizzolitto S; Pandolfi M; Fasola G; Piga A; Puglisi F
Ann Oncol; 2009 Feb; 20(2):265-71. PubMed ID: 18765464
[TBL] [Abstract][Full Text] [Related]
20. [Molecular basis for the inhibition of anticancer agents-induced apoptosis by thymidine phosphorylase].
Ikeda R
Yakugaku Zasshi; 2007 Jul; 127(7):1097-102. PubMed ID: 17603269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
